Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis

Completed · Phase 2

Conditions studied: Pouchitis

In brief

Phase 2 Study Investigating the Efficacy of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis

Key facts

Study ID

NCT04741087

Run by

Applied Molecular Transport

People needed

22

Starts

2021-02-05

Expected to finish

2022-04-22

Last updated by the study team

2022-09-14

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Chronic or recurrent pouchitis

You may not qualify if…

• Known gastrologic, or systemic condition that may compromise severity or diagnosis of disease.
• History or current evidence of colonic or abdominal abnormalities.
• Previous exposure to AMT-101 or similar and known hypersensitivity to AMT-101 or its excipients.

Where it is running

• Connecticut Clinical Research Institute — Bristol, Connecticut, United States
• University of Chicago Medical Center — Chicago, Illinois, United States
• Chevy Chase Clinical Research — Chevy Chase, Maryland, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Gastrointestinal Associates - Jackson — Flowood, Mississippi, United States
• University of North Carolina GI — Chapel Hill, North Carolina, United States
• Gastro One — Germantown, Tennessee, United States
• Gastrointestinal Asssociates- GIA Clinical Trials, LLC — Knoxville, Tennessee, United States
• Vanderbilt University Medical Center — Nashville, Tennessee, United States
• Tyler Research Institute, LLC — Tyler, Texas, United States
• University of Utah Health Sciences Center — Salt Lake City, Utah, United States
• Washington Gastroenterology, Tacoma — Tacoma, Washington, United States
• UZ Leuven - University Hospital Gasthuisberg — Leuven, Belgium
• Groupe santé CHC / Clinique du MontLégia, Liege — Liège, Belgium
• GI Research Institute — Vancouver, British Columbia, Canada
• CHU de Rennes - Hopital de Pontchaillou — Rennes, France
• CHU Saint Etienne - Hopital Nord — Saint-Priest-en-Jarez, France
• CHU de Toulouse - Hôpital Rangueil — Toulouse, France
• CHRU Nancy - Hopital de Brabois — Vandœuvre-lès-Nancy, France
• Praxis fur Gastroenterologie am Bayerischen Platz — Berlin, Germany
• Klinik für Innere Medizin KIM IV — Jena, Germany
• UKSH Universitätsklinikum Schleswig-Holstein — Kiel, Germany
• University Hospital Tübingen — Tübingen, Germany
• Semmelweis Egyetem I. sz Belgyogyaszati Klinika — Budapest, Hungary
• Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar — Szeged, Hungary

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.